FDC has received final approval from U.S. Food and Drug Administration (USFDA) for the Company’s Abbreviated New Drug Application (ANDA) for Cefixime 400 mg Tablets.
In November 2024, FDC recalled 1,55,232 bottles of Timolol Maleate ophthalmic solution in the US market. The company recalled the affected lot due to ‘Defective Container: Unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle.’
FDC is among India’s leading fully integrated pharmaceutical companies.
